Evolent Health (EVH) Short term Debt (2020 - 2025)
Evolent Health (EVH) recorded quarterly Short term Debt of $5.1 million in Q3 2025, down 97.03% quarter-over-quarter from $172.1 million in Q2 2025.
Evolent Health (EVH) Short term Debt (2020 - 2025) Analysis & Trends
Evolent Health's Short term Debt history runs 5 years deep, the most recent figure standing at $5.1 million for Q3 2025.
- In Q3 2025, Short term Debt changed N/A year-over-year to $5.1 million; the TTM figure through Sep 2025 stood at $5.1 million (changed N/A YoY), while the FY2024 annual figure was $171.5 million, changed N/A from the prior year.
- Short term Debt was $5.1 million for Q3 2025 at Evolent Health, down from $172.1 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $172.1 million in Q2 2025 to a low of $991000.0 in Q3 2023.
- Historically, Short term Debt has averaged $75.2 million across 4 years, with a median of $26.7 million in 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Evolent Health | 501.33 Mn | 335.36 Mn | 83.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.12 Mn |
| Jun 30, 2025 | 172.12 Mn |
| Mar 31, 2025 | 171.79 Mn |
| Dec 31, 2024 | 171.47 Mn |
| Sep 30, 2023 | 991,000.00 |
| Sep 30, 2021 | 26.70 Mn |
| Jun 30, 2021 | 26.66 Mn |
| Mar 31, 2021 | 26.61 Mn |
| Dec 31, 2020 | 26.56 Mn |